Ingalls & Snyder LLC Immuno Precise Antibodies Ltd. Transaction History

Ingalls & Snyder LLC

$3.04 Billion
Q1 2025

A detailed history of Ingalls & Snyder LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 2,758,127 shares of IPA stock, worth $1.46 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,758,127

Previous 1,561,332 76.65%

Holding current value

$1.46 Million

Previous $643,000 61.43%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$0.28 - $0.64 $335,102 - $765,948	1,196,795 Added 76.65%	2,758,127 $1.04 Million
Q4 2024 Jan 29, 2025	BUY	$0.34 - $0.68 $829 - $1,659	2,440 Added 0.16%	1,561,332 $643,000
Q3 2024 Nov 14, 2024	BUY	$0.54 - $1.04 $142,263 - $273,989	263,451 Added 20.34%	1,558,892 $996,000
Q2 2024 Jul 31, 2024	BUY	$0.98 - $1.53 $6,767 - $10,566	6,906 Added 0.54%	1,295,441 $1.31 Million
Q1 2024 May 13, 2024	BUY	$1.4 - $2.41 $10,122 - $17,424	7,230 Added 0.56%	1,288,535 $1.96 Million
Q4 2023 Jan 29, 2024	BUY	$1.11 - $2.3 $280,887 - $582,019	253,052 Added 24.61%	1,281,305 $2.19 Million
Q3 2023 Nov 02, 2023	SELL	$1.76 - $3.04 $55,971 - $96,678	-31,802 Reduced 3.0%	1,028,253 $1.88 Million
Q2 2023 Jul 27, 2023	BUY	$2.42 - $4.04 $4,888 - $8,160	2,020 Added 0.19%	1,060,055 $3.14 Million
Q1 2023 May 09, 2023	BUY	$2.77 - $5.49 $243,449 - $482,505	87,888 Added 9.06%	1,058,035 $2.93 Million
Q4 2022 Jan 31, 2023	BUY	$4.5 - $5.72 $13,756 - $17,486	3,057 Added 0.32%	970,147 $5.05 Million
Q3 2022 Oct 21, 2022	BUY	$3.77 - $6.39 $104,108 - $176,459	27,615 Added 2.94%	967,090 $3.86 Million
Q2 2022 Aug 11, 2022	BUY	$3.8 - $6.08 $27,645 - $44,232	7,275 Added 0.78%	939,475 $3.57 Million
Q1 2022 May 09, 2022	BUY	$3.64 - $6.49 $407,468 - $726,503	111,942 Added 13.65%	932,200 $4.79 Million
Q4 2021 Feb 11, 2022	BUY	$5.06 - $6.69 $1.01 Million - $1.33 Million	198,811 Added 31.99%	820,258 $4.4 Million
Q3 2021 Oct 27, 2021	BUY	$5.14 - $13.22 $106,074 - $272,821	20,637 Added 3.43%	621,447 $3.87 Million
Q2 2021 Aug 03, 2021	BUY	$6.02 - $12.91 $503,362 - $1.08 Million	83,615 Added 16.17%	600,810 $3.62 Million
Q1 2021 Apr 21, 2021	BUY	$8.84 - $17.0 $1.07 Million - $2.05 Million	120,770 Added 30.46%	517,195 $5.08 Million
Q4 2020 Jan 27, 2021	BUY	$6.15 - $18.7 $2.44 Million - $7.41 Million	396,425 New	396,425 $5.93 Million

Others Institutions Holding IPA

# of Institutions

Shares Held

3.93M

Call Options Held

27.2K

Put Options Held

View Full List

About ImmunoPrecise Antibodies Ltd.

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $13.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

More about IPA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Immuno Precise Antibodies Ltd. Transaction History